INTELLIGENT BIO SOLUTIONS INC. (INBS)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Jun 30
In fiscal 2025, INTELLIGENT BIO SOLUTIONS INC. reported revenue of $3.05M, down 1.9% from the prior year. The company ran a net loss, with a net margin of -346.2% and a gross margin of 40.8%. It held $8.25M in total assets against $5.44M in total liabilities.
Key ratios (FY2025)
40.8%
Gross margin
-348.7%
Operating margin
-346.2%
Net margin
-352.7%
Return on equity
-1.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $3.05M | $3.11M | $1.26M | $437.1K | $1.98M | — | — |
| Cost of Revenue | $1.81M | $1.69M | $930.2K | — | — | — | — |
| Gross Profit | $1.25M | $1.43M | $326.7K | — | — | — | — |
| Operating Income | -$10.64M | -$10.28M | -$12.60M | -$8.34M | -$5.57M | -$2.86M | — |
| Net Income | -$10.57M | -$10.16M | -$10.63M | -$8.31M | -$7.04M | -$3.16M | — |
| EPS (Diluted) | $-2.00 | $-6.38 | $-127.00 | $-11.33 | $-0.68 | — | — |
| Total Assets | $8.25M | $13.78M | $10.35M | $12.35M | $21.86M | $2.48M | — |
| Total Liabilities | $5.44M | $5.60M | $6.67M | $5.81M | $6.85M | $7.69M | — |
| Shareholders' Equity | $3.00M | $8.33M | $3.80M | $6.62M | $15.06M | -$5.19M | -$3.98M |
| Cash & Equivalents | $1.02M | $6.30M | $1.54M | $8.24M | $12.57M | $427.3K | — |
| Operating Cash Flow | -$9.68M | -$9.57M | -$7.38M | -$3.36M | -$11.30M | -$498.6K | — |
| Capital Expenditures | $231.8K | $221.4K | — | — | — | — | — |
| Shares Outstanding | 7.32M | 3.46M | 194.2K | 14.89M | 13.58M | 8.63M | — |